evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract
7243,GENE_BACKGROUND,,"ALK encodes a receptor tyrosine kinase in the insulin receptor family that plays an important role in nervous system development. In cancer, ALK gene fusions with a variety of translocation partners result in aberrant activation of mitogenic and anti-apoptotic signaling pathways, including STAT3, MAPK and PI3K pathways (PMID: 24715763). Mutations and deletions in the ALK gene are less common than translocations. Cancer types with ALK alterations include non-small cell lung cancer (NSCLC), anaplastic large cell lymphoma, inflammatory myofibroblastic tumor (IMT), neuroblastoma, and rhabdomyosarcoma (PMID: 24060861).",,2017-04-28,,238,ALK,anaplastic lymphoma receptor tyrosine kinase,True,ENST00000389048,NM_004304.4,NBLST3,CD246,False,24715763,ALK-driven tumors and targeted therapy: focus on crizotinib.,Pharmacogenomics and personalized medicine,2014,7,,87-94,Murga-Zamalloa C et al,doi: 10.2147/PGPM.S37504,,Murga-Zamalloa C et al. Pharmacogenomics and personalized medicine. 2014;7()87-94.,,24060861,Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.,Nature reviews. Cancer,2018-10-01T20:13:00,13,10,685-700,Hallberg B et al,doi: 10.1038/nrc3580,,2018-10-01T07:00:00,
7242,GENE_SUMMARY,,"ALK, a receptor tyrosine kinase, is recurrently altered by chromosomal rearrangements in various cancers including anaplastic large cell lymphoma, non-small cell lung cancer and inflammatory myofibroblastic tumor.",,2017-05-02,,238,ALK,anaplastic lymphoma receptor tyrosine kinase,True,ENST00000389048,NM_004304.4,NBLST3,CD246,False,,,,,,,,,,,,,,,,,,,,,,,,
